Op den Kamp YJM, de Ligt M, Dautzenberg B, Kornips E, et al. Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care 2021 Apr 15. pii: dc20-2887. doi: 10.2337/dc20-2887.
PMID: 33858855